Cell-Based Therapy for Silicosis

Cell-Based Therapy for Silicosis

Silicosis is the most common pneumoconiosis globally, with higher prevalence and incidence in developing countries. To date, there is no effective treatment to halt or reverse the disease progression caused by silica-induced lung injury. Significant advances have to be made in order to reduce morbidity and mortality related to silicosis. In this review, we have highlighted the main mechanisms o...

Stem Cell-Based Therapy (Cell Therapy) in Iran and other Countries

Cell therapy is a modern approach in the treatment of most of the diseases which uses stem cells and it has been recently developed rapidly. Cell therapy has shown satisfactory results in this way. Our country, Iran, has played an important role in the development of this new method and the results of stem cell treatment used for the most of the diseases were successful. The results have led to...

Stem Cell-Based Cell Therapy for Glomerulonephritis

Glomerulonephritis (GN), characterized by immune-mediated inflammatory changes in the glomerular, is a common cause of end stage renal disease. Therapeutic options for glomerulonephritis applicable to all cases mainly include symptomatic treatment and strategies to delay progression. In the attempt to yield innovative interventions fostering the limited capability of regeneration of renal tissu...

Silicosis: cluster in sandblasters--Texas, and occupational surveillance for silicosis.

In November 1988, a physician in west Texas reported three cases of silicosis in sandblasters to the Ector County Health Department (ECHD). One of the workers, a 34-year-old man, subsequently died with acute silicotic alveolar proteinosis. All three workers had been employed at a facility that sandblasted oil-field drilling pipes. Following the physician's report, in January 1989, the ECHD and ...

cell therapy for dermal reconstruction